1. Extending Treatment for Thrombosis: What’s the Right Choice?

3. Program Goals

4. VTE: Acute, Long-Term, and Extended Treatment

5. "Provoked" VTE

6. Unprovoked VTE

7. Role of Gender in VTE AUREC

8. Role of Gender REVERSE

9. Other Factors

10. VTE Extension Trials Efficacy and Safety Outcomes

11. Aspirin for the Prevention of Recurrent VTE: INSPIRE

12. Duration of Anticoagulation Transient Risk Factors

13. Duration of Anticoagulation Persistent Risk Factors

14. EINSTEIN CHOICE Study Design

15. EINSTEIN CHOICE: Demographics and Clinical Characteristics

16. EINSTEIN CHOICE Cause of VTE

17. EINSTEIN CHOICE: Primary Outcome Recurrent VTE

18. EINSTEIN CHOICE Recurrent VTE by Risk Factor Profile

19. EINSTEIN CHOICE: Bleeding Outcomes

20. EINSTEIN CHOICE Impact on Clinical Practice

21. Real-World Data

22. EINSTEIN CHOICE Summary

23. Placebo Arms VTE Extension Trials

24. Summary

25. Abbreviations